Alexandra Gratl1, Jan Frese2, Fiona Speichinger2, Dominik Pesta3, Andreas Frech4, Safwan Omran2, Andreas Greiner2. 1. Department of Vascular Surgery, Charité - Medical University of Berlin, Berlin, Germany; Department of Vascular Surgery, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: alexandra.gratl@i-med.ac.at. 2. Department of Vascular Surgery, Charité - Medical University of Berlin, Berlin, Germany. 3. Institute for Clinical Diabetology, German Diabetes Centre, Leibniz Institute for Diabetes Research, Heinrich Heine University, Düsseldorf, Germany; German Centre for Diabetes Research (DZD), München-Neuherberg, Germany; Department of Sports Science, Medical Section, University of Innsbruck, Innsbruck, Austria. 4. Department of Vascular Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Abstract
OBJECTIVE: Myopathy, characterised by altered mitochondrial function, is a central part of the pathophysiology of peripheral arterial disease and the aim of this study was to investigate the effect of revascularisation on mitochondrial function. METHODS: High resolution respirometry was used to investigate mitochondrial respiration and the results were normalised to citrate synthase activity (CSA), a marker of mitochondrial content. Ten patients with symptomatic peripheral arterial disease (study group) and 10 subjects without ischaemia (control group) were included. Ankle brachial index and ultrasound imaging were performed before and after vascular intervention to confirm technically successful revascularisation. Within the study group, muscle biopsies from the gastrocnemius muscle were taken before vascular intervention and six weeks after revascularisation. Within the control group, tissue was harvested once. RESULTS: There were no significant group differences regarding anthropometric data. CSA showed a significant increase after successful revascularisation (CSA pre-operative 281.4 (252.4-391.8) nmol/min/mg protein vs. CSA post-operative 438.5 (361.4-471.3) nmol/min/mg protein; p = .01) with post-operative return of values to the range of control subjects (CSA control 396.6 (308.2-435.9)). Mitochondrial respiration normalised to CSA in oxidative phosphorylation (P) as well as in electron transfer (E) capacity were significantly reduced post-operatively when compared with pre-operative values (P pre-operative 0.218 (0.196-0.266) pmol/(sec×mg) per CSA vs. post-operative 0.132 (0.116-0.150) pmol/(sec×mg) per CSA, p = .007; E pre-operative 0.230 (0.195-0.279) pmol/(sec×mg) per CSA vs. post-operative 0.129 (0.120-0.154) pmol/(sec×mg) per CSA, p = .005) meaning a post-operative return of values to within the range of control subjects (P control 0.124 (0.080-0.155) pmol/(sec×mg) per CSA; E control 0.121 (0.079-0.125) pmol/(sec×mg) per CSA). CONCLUSION: With these results, it has been shown that the initially impaired mitochondrial function and content can normalise after revascularisation.
OBJECTIVE:Myopathy, characterised by altered mitochondrial function, is a central part of the pathophysiology of peripheral arterial disease and the aim of this study was to investigate the effect of revascularisation on mitochondrial function. METHODS: High resolution respirometry was used to investigate mitochondrial respiration and the results were normalised to citrate synthase activity (CSA), a marker of mitochondrial content. Ten patients with symptomatic peripheral arterial disease (study group) and 10 subjects without ischaemia (control group) were included. Ankle brachial index and ultrasound imaging were performed before and after vascular intervention to confirm technically successful revascularisation. Within the study group, muscle biopsies from the gastrocnemius muscle were taken before vascular intervention and six weeks after revascularisation. Within the control group, tissue was harvested once. RESULTS: There were no significant group differences regarding anthropometric data. CSA showed a significant increase after successful revascularisation (CSA pre-operative 281.4 (252.4-391.8) nmol/min/mg protein vs. CSA post-operative 438.5 (361.4-471.3) nmol/min/mg protein; p = .01) with post-operative return of values to the range of control subjects (CSA control 396.6 (308.2-435.9)). Mitochondrial respiration normalised to CSA in oxidative phosphorylation (P) as well as in electron transfer (E) capacity were significantly reduced post-operatively when compared with pre-operative values (P pre-operative 0.218 (0.196-0.266) pmol/(sec×mg) per CSA vs. post-operative 0.132 (0.116-0.150) pmol/(sec×mg) per CSA, p = .007; E pre-operative 0.230 (0.195-0.279) pmol/(sec×mg) per CSA vs. post-operative 0.129 (0.120-0.154) pmol/(sec×mg) per CSA, p = .005) meaning a post-operative return of values to within the range of control subjects (P control 0.124 (0.080-0.155) pmol/(sec×mg) per CSA; E control 0.121 (0.079-0.125) pmol/(sec×mg) per CSA). CONCLUSION: With these results, it has been shown that the initially impaired mitochondrial function and content can normalise after revascularisation.
Authors: Ahmed Ismaeel; Emma Fletcher; Dimitrios Miserlis; Marissa Wechsler; Evlampia Papoutsi; Gleb Haynatzki; Robert S Smith; William T Bohannon; Panagiotis Koutakis Journal: Transl Res Date: 2022-03-12 Impact factor: 10.171
Authors: Ram B Khattri; Kyoungrae Kim; Trace Thome; Zachary R Salyers; Kerri A O'Malley; Scott A Berceli; Salvatore T Scali; Terence E Ryan Journal: J Clin Med Date: 2021-02-02 Impact factor: 4.241
Authors: Larissa Schawe; Ben Raude; Jan Christoph Carstens; Irene Hinterseher; Raphael Donatus Hein; Safwan Omran; Gilles Berger; Nina A Hering; Matthias Buerger; Andreas Greiner; Jan Paul Frese Journal: Biomedicines Date: 2022-02-17
Authors: Jon Stavres; Jianli Wang; Christopher T Sica; Cheryl Blaha; Michael Herr; Samuel Pai; Aimee Cauffman; Jeffrey Vesek; Qing X Yang; Lawrence I Sinoway Journal: Eur J Appl Physiol Date: 2021-06-09 Impact factor: 3.078